BioLife Solutions, Inc. (FRA:BJX1)
Germany
· Delayed Price · Currency is EUR 21.60
0.00 (0.00%)
At close: Dec 4, 2025
BioLife Solutions Revenue
BioLife Solutions had revenue of $28.07M USD in the quarter ending September 30, 2025, with 31.21% growth. This brings the company's revenue in the last twelve months to $100.14M, up 87.53% year-over-year. In the year 2024, BioLife Solutions had annual revenue of $82.25M with 8.44% growth.
Revenue (ttm)
$100.14M
Revenue Growth
+87.53%
P/S Ratio
12.35
Revenue / Employee
$629.84K
Employees
159
Market Cap
1.05B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82.25M | 6.40M | 8.44% |
| Dec 31, 2023 | 75.86M | -384.00K | -0.50% |
| Dec 31, 2022 | 76.24M | -42.92M | -36.02% |
| Dec 31, 2021 | 119.16M | 71.07M | 147.79% |
| Dec 31, 2020 | 48.09M | 20.72M | 75.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |